Use and limitations of alum‐based models of allergy
- 16 July 2008
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 38 (10) , 1572-1575
- https://doi.org/10.1111/j.1365-2222.2008.03069.x
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Toll‐like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin‐specific allergic airway disease: role of MyD88 adaptor molecule and interleukin‐12/interferon‐γ axisClinical and Experimental Allergy, 2008
- Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvantsNature, 2008
- Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cellsThe Journal of Experimental Medicine, 2008
- Discovering susceptibility genes for asthma and allergyNature Reviews Immunology, 2008
- Animal models of chronic experimental asthma — strategies for the identification of new therapeutic targetsJournal of Occupational Medicine and Toxicology, 2008
- A mechanism for the initiation of allergen-induced T helper type 2 responsesNature Immunology, 2007
- How Do Adjuvants Work? Important Considerations for New Generation AdjuvantsImmunity, 2007
- Chitin induces accumulation in tissue of innate immune cells associated with allergyNature, 2007
- Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor SignalingScience, 2006
- Murine models of asthmaEuropean Respiratory Journal, 2003